Evommune EVMN Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's increase (decrease) in accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's increase (decrease) in accounts receivable?
- Evommune (EVMN) reported increase (decrease) in accounts receivable of -$145.76K in Q1 2026.
- How has Evommune 's increase (decrease) in accounts receivable changed year-over-year?
- Evommune 's increase (decrease) in accounts receivable decreased by 2395.5% year-over-year, from -$5.84K to -$145.76K.
- What does increase (decrease) in accounts receivable mean?
- Represents the net change in the balance of amounts owed to the company by customers for goods or services delivered on credit. An increase indicates that revenue recognition is outpacing cash collection, which may impact short-term liquidity. Monitoring this helps assess the effectiveness of the company's credit and collection policies.